Where can I buy Sotoracib (AMG510)?

Sotorracib (AMG510)is a novel oral anticancer drug classified as aKRAS G12Cinhibitor. KRAS (Kirsten Rat Sarcoma Viral Oncogene Homolog) is a common oncogene that is found in a variety of cancers, including non-small cell lung cancer (NSCLC). KRAS G12C is a common type of KRAS gene mutation, especially in NSCLC patients.

Since sotoracib is not yet available in China, domestic patients cannot purchase it directly. However, they can choose to obtain the drug through overseas routes. The overseas market for sotoraxib includes both original drugs and generic drugs. In terms of original drugs, there are mainly European versions andHong Kong versions of drugs, but their prices are quite expensive, usually reaching tens of thousands of yuan.

In comparison, the prices of generic drugs in foreign markets are more affordable. Taking generic drugs in Laos as an example, the prices of Lao Lucius and Lao Big Bear drugs have recently been significantly reduced. The current price is about between one thousand and two thousand yuan, which undoubtedly relieves a lot of financial pressure on patients. It is worth mentioning that the ingredients of these original drugs and generic drugs are basically the same.

The mechanism of action of Sotoraxib is to target the KRAS G12C mutation. By inhibiting the activity of this mutation KRAS, it blocks the signal transduction of cancer cell proliferation, thereby inhibiting the growth of tumors. The development and application of this drug is of great significance because KRAS has long been considered a difficult-to-target oncogene, and the advent of sotoracib has brought new hope for the treatment of KRAS mutations.

Clinical trials have shown that sotorasiib has shown certain efficacy in the treatment of patients with advanced or metastatic NSCLC harboring KRAS G12C mutations, and has been approved for clinical treatment in some countries. This provides a new treatment option for patients who previously had no effective treatment options.

However, sotoracib also has some potential side effects and safety issues. Like other drugs, it may cause a series of adverse reactions, including but not limited to nausea, vomiting, diarrhea, fatigue, etc. Therefore, before using sotorasiib, doctors will conduct a thorough evaluation of the patient and weigh the possible benefits and risks.